Checklist for standardized reporting of drug-drug interaction management guidelines

Checklist for standardized reporting of drug-drug interaction management guidelines

Показать другие версии (1)

Purpose: Inconsistencies and omissions in drug-drug interaction (DDI) management guidelines may lead to harm and suboptimal therapy. The purpose of this study was to define a checklist for DDI management guidelines to help developers produce high-quality guidelines that will support healthcare provi...

Полное описание

Библиографические подробности
Главные авторы:	Floor-Schreudering, A, Geerts, A, Aronson, J, Bouvy, M, Ferner, R, De Smet, P
Формат:	Journal article
Язык:	English
Опубликовано:	2014

Схожие документы

Checklist for standardized reporting of drug-drug interaction management guidelines.
по: Floor-Schreudering, A, и др.
Опубликовано: (2014)

Towards improved drug-drug interaction management guidelines
по: Floor-Schreudering, A, и др.
Опубликовано: (2013)

Pharmacogenetics and adverse drug reactions
по: Ferner, R, и др.
Опубликовано: (2010)

Clarification of terminology in drug safety.
по: Aronson, J, и др.
Опубликовано: (2005)

Communicating information about drug safety.
по: Ferner, R, и др.
Опубликовано: (2006)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
по: Aronson, J, и др.
Опубликовано: (2010)

National differences in publishing papers on adverse drug reactions.
по: Ferner, R, и др.
Опубликовано: (2005)

EIDOS: a mechanistic classification of adverse drug effects.
по: Ferner, R, и др.
Опубликовано: (2010)

The toxicological significance of post-mortem drug concentrations in bile
по: Ferner, RE, и др.
Опубликовано: (2017)

Monitoring for the Adverse Effects of Drugs
по: Coleman, J, и др.
Опубликовано: (2008)

Joining the DoTS: new approach to classifying adverse drug reactions.
по: Aronson, J, и др.
Опубликовано: (2003)

Preventability of drug-related harms - part I: a systematic review.
по: Ferner, R, и др.
Опубликовано: (2010)

Defining rewardable innovation in drug therapy.
по: Aronson, J, и др.
Опубликовано: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
по: McDowell, SE, и др.
Опубликовано: (2013)

Nominal ISOMERs (Incorrect spellings of medicines eluding researchers)-variants in the spellings of drug names in PubMed: a database review
по: Ferner, R, и др.
Опубликовано: (2016)

Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity
по: Ferner, RE, и др.
Опубликовано: (2022)

Serious drug interactions.
по: Aronson, J
Опубликовано: (1993)

Classifying drug interactions.
по: Aronson, J
Опубликовано: (2004)

Beneficial drug interactions.
по: Aronson, J
Опубликовано: (1994)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
по: Aronson, J
Опубликовано: (2008)

Designing and Psychometry of the Evaluation Checklist for the Registration and Labeling Guidelines of Anesthetic Drugs in the Operating Room
по: Parisa Moradimajd, и др.
Опубликовано: (2023-01-01)

Reporting guidelines for human microbiome research: the STORMS checklist
по: Mirzayi, C, и др.
Опубликовано: (2021)

Communicating information about drug interactions
по: Aronson, J
Опубликовано: (2007)

Interactions that matter: 10 Antiarrhythmic drugs
по: Aronson, J
Опубликовано: (1987)

Reporting guideline checklists are not quality evaluation forms: they are guidance for writing
по: Logullo, P, и др.
Опубликовано: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
по: Aronson, Jeffrey K.
Опубликовано: (2006)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
по: Aronson, J
Опубликовано: (2005)

The reporting checklist for public versions of guidelines: RIGHT-PVG
по: Xiaoqin Wang, и др.
Опубликовано: (2021-01-01)

RMJ research series – Using a Reporting Guideline (Checklist)
по: D. Hopkinson, и др.
Опубликовано: (2020-03-01)

Checking and correction of drug information in the standards of care and clinical guidelines
по: B. K. Romanov
Опубликовано: (2018-02-01)

Clinical pharmacology. Adverse drug interactions.
по: Aronson, J, и др.
Опубликовано: (1981)

Reporting Guidelines for Healthcare Guideline Adaptations: An Interpretation of the RIGHT-Ad@pt Checklist
по: GONG Liyun, и др.
Опубликовано: (2024-11-01)

Drug interactions-information, education, and the British National Formulary.
по: Aronson, J
Опубликовано: (2004)

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.
по: Hauben, M, и др.
Опубликовано: (2007)

STAGER checklist: Standardized testing and assessment guidelines for evaluating generative artificial intelligence reliability
по: Jinghong Chen, и др.
Опубликовано: (2024-09-01)

The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM
по: Xuanlin Li, и др.
Опубликовано: (2024-01-01)

iCHECK-DH: Guidelines and Checklist for the Reporting on Digital Health Implementations
по: Caroline Perrin Franck, и др.
Опубликовано: (2023-05-01)

Guidelines of research biosimilar drugs
по: R. . Ivanov, и др.
Опубликовано: (2014-04-01)

Pharmacokinetic drug-drug interaction and their implication in clinical management
по: Palleria Caterina, и др.
Опубликовано: (2013-01-01)

Adverse drug reactions: definitions, diagnosis, and management.
по: Edwards, I, и др.
Опубликовано: (2000)